Conference Coverage

Targeting inactivity, mood, and cognition could be key to reducing OA mortality


 

REPORTING FROM OARSI 2018


After adjustment for potential confounding factors, such as age, NSAID use, and common comorbidities, the increased mortality risk remained, with around a 15% increased risk of death for those with OA versus those without.

“We proposed six different mediators of this relationship,” Mr. Parmar said. These were depression, anxiety, low walking frequency, cognitive impairment, insomnia, and obesity. “The reason we chose these is because they can be targets for therapy in primary care.”


Three mediators significantly affected the relationship: low walking frequency, depression, and cognitive impairment; the respective hazard ratios and 95% confidence intervals were 1.12 (1.09-1.15), 1.11 (1.08-1.15), and 1.06 (1.03-1.09).

“This tells us that these could possibly be on the pathway between osteoarthritis and mortality, and this could provide further evidence that they could be used for targeted therapy of osteoarthritis,” Mr. Parmar suggested.

Pages

Recommended Reading

Esketamine nasal spray brings fast relief of depressive symptoms
MDedge Family Medicine
Change in approach advised for treatment-resistant depression
MDedge Family Medicine
Focus on early maladaptive schemas can reduce PTSD burden
MDedge Family Medicine
Suicide prevention, NRA team up for safer gun storage
MDedge Family Medicine
Fetal exposure to depression: How does ‘dose’ figure in?
MDedge Family Medicine
Suicide on the minds of many Utah teens
MDedge Family Medicine
Ketamine formulation study is ‘groundbreaking’
MDedge Family Medicine
Hidradenitis suppurativa packs mighty QOL impact
MDedge Family Medicine
Anticholinergics’ link to dementia calls for vigilance in elderly
MDedge Family Medicine
VIDEO: National suicide hotline could result from pending U.S. law
MDedge Family Medicine